Growth Metrics

Supernus Pharmaceuticals (SUPN) Amortizatization of Intangibles: 2017-2025

Historic Amortizatization of Intangibles for Supernus Pharmaceuticals (SUPN) over the last 9 years, with Sep 2025 value amounting to $921,000.

  • Supernus Pharmaceuticals' Amortizatization of Intangibles rose 195.34% to $921,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 183.78%. This contributed to the annual value of -$1.8 million for FY2024, which is 1594.26% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Amortizatization of Intangibles is $921,000, which was up 2,778.12% from $32,000 recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $1.7 million in Q1 2021 and a low of -$2.1 million during Q3 2022.
  • For the 3-year period, Supernus Pharmaceuticals' Amortizatization of Intangibles averaged around $29,636, with its median value being $32,000 (2025).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first soared by 585.14% in 2021, then crashed by 3,938.89% in 2023.
  • Supernus Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at -$1.3 million in 2021, then surged by 98.57% to -$18,000 in 2022, then plummeted by 3,938.89% to -$727,000 in 2023, then surged by 192.71% to $674,000 in 2024, then spiked by 195.34% to $921,000 in 2025.
  • Its Amortizatization of Intangibles was $921,000 in Q3 2025, compared to $32,000 in Q2 2025 and $1.1 million in Q1 2025.